All News about AbbVie
What 8 Analyst Ratings Have To Say About AbbVie
November 18, 2022
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 18, 2022
November 18, 2022
Via Benzinga
AbbVie's Migraine Treatment Scores Canadian Approval
November 16, 2022
Via Benzinga
Exicure Flags Bankruptcy Concerns, Shares Fall
November 15, 2022
Via Benzinga
One in Five Americans Who Have Been Infected With the Virus Said to Have Long COVID
November 17, 2022
Exposures
COVID-19
Can AbbVie Grow Revenue When Humira Biosimilars Hit The Market?
November 16, 2022
Via MarketBeat
Topics
Intellectual Property
Exposures
Intellectual Property
Control Of Congress Up For Grabs In Midterms: 12 Stocks To Watch
November 07, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|